SHIRE Released : Feb 24, 2017 10:00
Director/PDMR Shareholding
February 24, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG)
Notification of transactions by person discharging managerial responsibilities
and person closely associated with them
1. Details of the person discharging managerial responsibilities
('PDMR') / person closely associated them ('PCA')
a) Name Albert Stroucken / Gerda Stroucken
2. Reason for the notification
a) Position / status Non-Executive Director (PDMR) / PCA of Albert
Stroucken
b) Initial Initial notification
notification /
amendment
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc American Depositary Shares ('ADSs')
the financial
instrument, type
of instrument
Identification ISIN: US82481R1068
code
b) Nature of the Joint acquisition of ADSs by PDMR and PCA
transaction
c) Price(s) and Price(s) Volume(s)
volume(s)
See appendix below
d) Aggregated Weighted average price Volume
information
$180.96 14,000
e) Date of the February 22, 2017
transaction
f) Place of the ARCX, BATS, BYXX, MSCO, NQBX, NQPX, NSDQ, XEDG
transaction
Appendix
Place of the Price(s) Volume(s)
transaction
ARCX $181.13 100
ARCX $180.93 47
ARCX $180.93 53
ARCX $180.91 100
ARCX $181.19 100
ARCX $181.17 100
ARCX $181.47 100
ARCX $181.37 100
ARCX $181.63 50
ARCX $181.45 100
ARCX $181.51 100
ARCX $181.51 100
ARCX $180.90 100
ARCX $180.98 100
ARCX $180.77 100
ARCX $180.57 100
ARCX $180.81 100
ARCX $180.83 100
ARCX $180.83 100
BATS $181.46 100
BATS $180.98 30
BATS $180.98 70
BATS $180.98 100
BATS $180.85 100
BATS $180.83 100
BYXX $181.33 100
BYXX $181.32 100
BYXX $181.44 12
BYXX $181.44 14
BYXX $180.85 100
MSCO $181.30 100
MSCO $181.95 100
MSCO $181.19 100
MSCO $180.89 300
MSCO $180.70 100
MSCO $180.75 100
MSCO $180.57 100
MSCO $180.47 100
MSCO $180.45 200
MSCO $180.63 100
MSCO $180.61 100
MSCO $180.52 100
MSCO $180.57 100
MSCO $180.50 100
MSCO $180.63 200
MSCO $180.82 100
MSCO $180.91 200
MSCO $180.91 200
MSCO $180.98 100
MSCO $180.91 400
MSCO $180.84 100
MSCO $180.88 100
MSCO $180.80 200
MSCO $180.84 100
MSCO $180.84 200
MSCO $180.69 200
MSCO $180.94 300
MSCO $180.98 100
MSCO $180.95 200
MSCO $180.83 100
MSCO $180.82 200
MSCO $181.04 3
NQBX $180.79 100
NQBX $180.96 100
NQPX $181.01 100
NSDQ $181.02 100
NSDQ $181.13 100
NSDQ $180.51 100
NSDQ $180.26 26
NSDQ $180.26 74
NSDQ $180.33 100
NSDQ $180.41 100
NSDQ $181.20 100
NSDQ $181.21 100
NSDQ $180.90 100
NSDQ $181.03 100
NSDQ $181.26 100
NSDQ $181.31 100
NSDQ $181.31 100
NSDQ $181.84 100
NSDQ $181.67 100
NSDQ $181.65 100
NSDQ $181.40 100
NSDQ $181.53 15
NSDQ $181.53 85
NSDQ $181.52 33
NSDQ $181.52 67
NSDQ $181.38 56
NSDQ $181.38 44
NSDQ $181.55 100
NSDQ $181.43 100
NSDQ $181.39 15
NSDQ $181.39 85
NSDQ $181.37 100
NSDQ $181.41 100
NSDQ $181.43 100
NSDQ $181.29 100
NSDQ $180.83 100
NSDQ $180.82 1
NSDQ $180.82 99
NSDQ $180.98 100
NSDQ $181.07 100
NSDQ $180.76 100
NSDQ $180.76 8
NSDQ $180.76 92
NSDQ $181.02 100
NSDQ $180.62 100
NSDQ $180.38 100
NSDQ $180.29 100
NSDQ $180.65 100
NSDQ $180.69 39
NSDQ $180.69 61
NSDQ $181.00 30
NSDQ $181.02 70
NSDQ $180.85 100
NSDQ $180.67 100
NSDQ $180.94 8
NSDQ $180.94 92
NSDQ $180.83 100
NSDQ $180.84 100
NSDQ $180.83 80
NSDQ $180.83 100
NSDQ $180.83 100
NSDQ $180.83 100
NSDQ $180.83 20
NSDQ $180.83 100
NSDQ $180.82 100
NSDQ $181.01 77
NSDQ $181.01 77
NSDQ $181.01 23
NSDQ $181.01 16
NSDQ $181.01 7
NSDQ $181.01 93
NSDQ $181.01 7
XEDG $180.61 100
XEDG $181.27 5
XEDG $181.27 95
XEDG $181.08 2
XEDG $181.08 98
XEDG $180.86 57
XEDG $180.86 43
XEDG $180.95 100
XEDG $181.17 100
XEDG $181.12 100
XEDG $180.92 100
XEDG $180.77 21
XEDG $180.87 100
XEDG $180.83 100
Place of the Weighted Aggregated
transaction average price volume
ARCX $181.09 1,750
BATS $181.02 500
BYXX $181.19 326
MSCO $180.83 4,703
NQBX $180.88 200
NQPX $181.01 100
NSDQ $181.01 5,400
XEDG $180.96 1,021
Total $180.96 14,000
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
Investor Relations
Ian Karp ikarp@shire.com +1 781 482 9018
Robert Coates rcoates@shire.com +44 1256 894874
Media
Lisa Adler lisa.adler@shire.com +1 617 588 8607
Debbi Ford debbi.ford@shire.com +1 617 949 9083
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on serving people
with rare diseases. We strive to develop best-in-class products, many of which
are available in more than 100 countries, across core therapeutic areas
including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage
Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary
Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and
deliver breakthrough therapies for the hundreds of millions of people in the
world affected by rare diseases and other high-need conditions, and who lack
effective therapies to live their lives to the fullest.
www.shire.com
Shire plc published this content on 24 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 24 February 2017 10:08:17 UTC.
Original documenthttp://otp.investis.com/clients/uk/shire/rns/regulatory-story.aspx?cid=1027&newsid=846955
Public permalinkhttp://www.publicnow.com/view/DD46CC992FE8BD9B11E283F547EA3A66EB5AA521
